C. Franke

Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.

A. Green, R. Clark, G. Vassiliou, 2003, Blood.

polyclonal hematopoiesis in the majority patients in cytogenetic remission to imatinib but restoration of cells in some CML - Emergence of clonal cytogenetic abnormalities in Ph

K. Krohn, M. Deininger, H. Al-Ali, 2012 .

Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation

M. Deininger, D. Niederwieser, H. Al-Ali, 2005, Leukemia.

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

K. Krohn, M. Deininger, D. Niederwieser, 2003, Blood.

The BCR/ABL-extra signal fluorescence in situ hybridization system reliably detects deletions upstream of the ABL locus: implications for reporting of results and followup of chronic myelogenous leukemia patients.

D. Niederwieser, R. Krahl, Christel Müller, 2002, Cancer genetics and cytogenetics.

Mesenchymal Stem Cells Remain Host-Derived Independent of the Source of the Stem-Cell Graft and Conditioning Regimen Used

D. Niederwieser, M. Cross, H. Al-Ali, 2009, Transplantation.

Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

K. Krohn, M. Deininger, D. Niederwieser, 2003, Blood.